# Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study

> **NCT02457286** · PHASE1 · WITHDRAWN · sponsor: **Northwell Health**

## Conditions studied

- Non-alcoholic Fatty Liver Disease (NAFLD)

## Interventions

- **DRUG:** Metformin
- **BEHAVIORAL:** Lifestyle modifications
- **DEVICE:** Fibroscan device (Echosens)

## Key facts

- **NCT ID:** NCT02457286
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** patients do not want to participate
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02457286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02457286, "Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02457286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*